Trial Profile
Comparison of safety and efficacy of telbivudine against lamivudine in interrupting perinatal transmission of hepatitis B virus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Dec 2015
Price :
$35
*
At a glance
- Drugs Lamivudine (Primary) ; Telbivudine (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- 05 Dec 2015 New trial record